Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D01LDQ
|
||||
| Former ID |
DNC011289
|
||||
| Drug Name |
Mycophenolic hydroxamic acid
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [531203] | ||
| Formula |
C17H21NO6
|
||||
| Canonical SMILES |
CC1=C(C(=C(C2=C1COC2=O)O)CC=C(C)CCC(=O)NO)OC
|
||||
| InChI |
1S/C17H21NO6/c1-9(5-7-13(19)18-22)4-6-11-15(20)14-12(8-24-17(14)21)10(2)16(11)23-3/h4,20,22H,5-8H2,1-3H3,(H,18,19)/b9-4+
|
||||
| InChIKey |
XUEGRBSFQYYISJ-RUDMXATFSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Inosine-5'-monophosphate dehydrogenase 1 | Target Info | Inhibitor | [531203] | |
| Inosine-5'-monophosphate dehydrogenase 2 | Target Info | Inhibitor | [531203] | ||
| BioCyc Pathway | Purine nucleotides degradation | ||||
| Urate biosynthesis/inosine 5'-phosphate degradation | |||||
| Guanosine nucleotides de novo biosynthesis | |||||
| Superpathway of purine nucleotide salvage | |||||
| Purine nucleotides de novo biosynthesis | |||||
| Guanosine ribonucleotides de novo biosynthesisPWY-6353:Purine nucleotides degradation | |||||
| Guanosine ribonucleotides de novo biosynthesis | |||||
| PANTHER Pathway | De novo purine biosynthesis | ||||
| PathWhiz Pathway | Purine Metabolism | ||||
| WikiPathways | Nucleotide Metabolism | ||||
| References | |||||